Skip to content
pH Pharma
  • About Us
    • 회사소개
    • 연혁
    • 경영진
    • 전략
    • 파트너
  • Pipeline
    • 후보물질
    • ADC
    • Sovesudil
  • Media
  • Careers
  • Contact Us
ko_KR KR
ko_KR KR en_US EN

[일:] 2022 5월 1

Regeneration of Corneal Endothelial Cells using pH Pharma’s ROCK Inhibitors presented at ARVO Annual Meeting

By AdminIn News작성일 2022-05-01

Results showing corneal endothelial cell regeneration with sovesudil (starting phase III clinical trial for glaucoma; also known as PHP-201) and PHP-961 was presented at the Association for Research in Vision and Ophthalmology Annual Meeting May 1st – 5th, 2022 (ARVO 2022). This study was conducted at Hallym University in collaboration...

More

최근 글

  • Regeneration of Corneal Endothelial Cells using pH Pharma’s ROCK Inhibitors presented at ARVO Annual Meeting
  • 신주발행 공고
  • 분할 공고
  • 구주권 제출 및 실효 공고
  • 기준일 및 명의개서 정지기간 설정공고

최근 댓글

    pH Pharma
    Copyright © 2023 pH Pharma | All Rights Reserved
    pH Pharma Co. LTD.

    B-1009, U-Space 2, 670 Daewangpangyo-ro,
    유스페이스2 B동 804호, 1009호

    (+82) 31-779-5330

    Contact

    LinkedIn